Rose-Hulman Institute of Technology has named Edwards Lifesciences Chairman and Chief Executive Officer Michael Mussallem to its board of trustees. Under his executive leadership since 2000, Edwards Lifesciences has been at the forefront of patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. The company collaborates with the world’s leading clinicians and researchers to address unmet health care needs, working to improve patient outcomes and enhance lives.

Mussallem serves on the board and executive committee of the Advanced Medical Technology Association and is a trustee of the University of California, Irvine Foundation. He is the former chairman of the board of directors of both AdvaMed and the California Healthcare Institute. His leadership of Edwards Lifesciences came when the company spun off from Baxter International, where he had held positions in engineering, product development and general management since 1979.

Mussallem earned a bachelor’s degree in chemical engineering from Rose-Hulman in 1974, received an honorary doctorate of engineering degree from the college in 1999 and was the featured speaker at the Institute’s 2015 commencement.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}